Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors

被引:74
|
作者
Mathew, Bijo [1 ,2 ]
Haridas, Abitha [3 ]
Ucar, Gulberk [4 ]
Baysal, Ipek [4 ]
Adeniyi, Adebayo A. [5 ]
Soliman, Mahmoud E. S. [5 ]
Joy, Monu [6 ]
Mathew, Githa Elizabeth [7 ]
Lakshmanan, Baskar [3 ]
Jayaprakash, Venkatesan [8 ]
机构
[1] Ahalia Sch Pharm, Div Drug Design, Palakkad 678557, Kerala, India
[2] Ahalia Sch Pharm, Med Chem Res Lab, Dept Pharmaceut Chem, Palakkad 678557, Kerala, India
[3] Grace Coll Pharm, Dept Pharmaceut Chem, Palakkad 678004, Kerala, India
[4] Hacettepe Univ, Dept Biochem, Fac Pharm, TR-06100 Ankara, Turkey
[5] Univ KwaZulu Natal, Sch Hlth Sci, ZA-4001 Durban, South Africa
[6] MG Univ, Sch Pure & Appl Phys, Kottayam, Kerala, India
[7] Grace Coll Pharm, Dept Pharmacol, Palakkad 678004, Kerala, India
[8] Birla Inst Technol, Dept Pharmaceut Sci & Technol, Ranchi 835215, Jharkhand, India
关键词
Thienyl chalcones; Human monoamine oxidase; Molecular docking; Molecular dynamics; ACCELERATED MOLECULAR-DYNAMICS; CURCUMIN-BASED DESIGN;
D O I
10.1016/j.ijbiomac.2016.05.110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chalcone has been reported to be a valid scaffold for the design of monoamine oxidase (MAO) inhibitors. This scenario has amplified the momentum for the discovery of heteroaryl based chalcone MAO inhibitors. In the present study, we have synthesized a series of eleven chlorinated thienyl chalcone derivatives substituted with a different functional groups at the para- position on the ring B and investigated for their ability to inhibit human MAO-A and-B. With the exception of compound (2E)-1-(4-chlorocyclopental,3-dien-1-yl)-3-(4-nitrophenyl)prop-2-en-1-one (TC7), which was a selective MAO-A inhibitor, all the other derivatives inhibited hMAO-B potently and selectively with competitive mode of inhibition. The most potent compound (2E)-1-(4-chlorocyclopenta-1,3-dien-1-yl)-3-(4-ethylphenyl)prop-2-en-1-one (TC6) was found to be the best activity and higher selectivity towards hMAO-B with Ki and SI values of 0.31 +/- 0.02 mu M and 16.84, respectively. All the compounds presented in the current study are completely non-toxic with 74-88% viable cells to hepatic cells at 100 M concentration. Molecular docking and molecular dynamics simulation studies were carried out using Autodock-4.2 and Amber 14 to understand the molecular level interaction and energy relation of MAO isoforms with selective MAO-B inhibitor TC6. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:680 / 695
页数:16
相关论文
共 50 条
  • [21] MONOAMINE OXIDASE-B IN ASTROCYTES
    EKBLOM, J
    JOSSAN, SS
    BERGSTROM, M
    ORELAND, L
    WALUM, E
    AQUILONIUS, SM
    GLIA, 1993, 8 (02) : 122 - 132
  • [22] Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
    Guglielmi, Paolo
    Mathew, Bijo
    Secci, Daniela
    Carradori, Simone
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 205
  • [23] Labware Additives Identified to Be Selective Monoamine Oxidase-B Inhibitors
    Stewart, Jeremy
    Drexler, Dieter M.
    Leet, John E.
    McNaney, Colleen A.
    Herbst, John J.
    JOURNAL OF BIOMOLECULAR SCREENING, 2014, 19 (10) : 1409 - 1414
  • [24] THE EFFECT OF MONOAMINE OXIDASE-A AND OXIDASE-B INHIBITORS ON RAT SERUM PROLACTIN
    KEANE, PE
    MENAGER, J
    BENEDETTI, MS
    NEUROPHARMACOLOGY, 1981, 20 (12A) : 1157 - 1162
  • [25] Trimethoxy Crown Chalcones as Multifunctional Class of Monoamine Oxidase Enzyme Inhibitors
    Maliyakkal, Naseer
    Baysal, Ipek
    Tengli, Anandkumar
    Ucar, Gulberk
    Almoyad, Mohammad Ali Abdullah
    Parambi, Della Grace Thomas
    Gambacorta, Nicola
    Nicolotti, Orazio
    Beeran, Asmy Appadath
    Mathew, Bijo
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25 (08) : 1314 - 1326
  • [26] Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
    Sasidharan, Rani
    Eom, Bo Hyun
    Heo, Jeong Hyun
    Park, Jong Eun
    Abdelgawad, Mohamed A.
    Musa, Arafa
    Gambacorta, Nicola
    Nicolotti, Orazio
    Manju, Sreedharannair Leelabaiamma
    Mathew, Bijo
    Kim, Hoon
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 188 - 197
  • [27] Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole
    Mathew, Bijo
    Baek, Seung C.
    Parambi, Della G. Thomas
    Lee, Jae P.
    Mathew, Githa E.
    Jayanthi, Sivaraman
    Devaraji, Vinod
    Rapheal, Clariya
    Vinod, Devikrishna
    Kondarath, Shahin Shad
    Uddin, Md. Sahab
    Kim, Hoon
    ARCHIV DER PHARMAZIE, 2019, 352 (04)
  • [28] Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry
    Cagide, F.
    Silva, T.
    Reis, J.
    Gaspar, A.
    Borges, F.
    Gomes, L. R.
    Low, J. N.
    CHEMICAL COMMUNICATIONS, 2015, 51 (14) : 2832 - 2835
  • [29] Two dimensional-QSAR and molecular dynamics studies of a selected class of aldoxime- and hydroxy-functionalized chalcones as monoamine oxidase-B inhibitors
    Mathew, Bijo
    Ravichandran, Veerasamy
    Raghuraman, Seenivasan
    Rangarajan, T. M.
    Abdelgawad, Mohamed A.
    Ahmad, Iqrar
    Patel, Harun M.
    Kim, Hoon
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (19): : 9256 - 9266
  • [30] Inhibition of rat brain monoamine oxidase-B by some monoamine reuptake inhibitors as antidepressants
    Arai, Y
    Satoh, N
    Uchida, N
    Nakagawasai, O
    Tadano, T
    Takeda, M
    Fujishiro, N
    Yasuhara, H
    BIOGENIC AMINES, 2002, 17 (01) : 25 - 30